T. C. M. Morris

759 total citations
40 papers, 530 citations indexed

About

T. C. M. Morris is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, T. C. M. Morris has authored 40 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Genetics and 11 papers in Oncology. Recurrent topics in T. C. M. Morris's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). T. C. M. Morris is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). T. C. M. Morris collaborates with scholars based in United Kingdom, Australia and Ireland. T. C. M. Morris's co-authors include H. Denis Alexander, Mark Catherwood, Christine Matthews, Z. R. Desai, V. L. S. Crawford, R. W. Stout, Mary Drake, J. H. Robertson, L. Nolan and J. M. Bridges and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Haematology.

In The Last Decade

T. C. M. Morris

38 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. C. M. Morris United Kingdom 13 189 152 148 138 123 40 530
Kazimierz Hałaburda Poland 12 171 0.9× 166 1.1× 102 0.7× 106 0.8× 126 1.0× 39 549
Tapio Nousiainen Finland 17 67 0.4× 203 1.3× 86 0.6× 83 0.6× 251 2.0× 32 647
Shoichi Inaba Japan 16 101 0.5× 274 1.8× 269 1.8× 26 0.2× 94 0.8× 61 681
Renée V. Gardner United States 16 220 1.2× 311 2.0× 58 0.4× 38 0.3× 124 1.0× 45 663
Nicolas Bachot France 10 81 0.4× 110 0.7× 112 0.8× 353 2.6× 55 0.4× 17 963
Volkan Hazar Türkiye 14 111 0.6× 197 1.3× 44 0.3× 42 0.3× 124 1.0× 53 575
Alan Brox Canada 13 120 0.6× 198 1.3× 49 0.3× 84 0.6× 91 0.7× 19 532
Prassede Salutari Italy 13 63 0.3× 220 1.4× 88 0.6× 28 0.2× 132 1.1× 40 438
Gustav Fischmeister Austria 13 48 0.3× 159 1.0× 65 0.4× 35 0.3× 92 0.7× 19 416
Kanchana Chansung Thailand 13 171 0.9× 339 2.2× 72 0.5× 23 0.2× 99 0.8× 40 544

Countries citing papers authored by T. C. M. Morris

Since Specialization
Citations

This map shows the geographic impact of T. C. M. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. C. M. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. C. M. Morris more than expected).

Fields of papers citing papers by T. C. M. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. C. M. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. C. M. Morris. The network helps show where T. C. M. Morris may publish in the future.

Co-authorship network of co-authors of T. C. M. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of T. C. M. Morris. A scholar is included among the top collaborators of T. C. M. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. C. M. Morris. T. C. M. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Włodarska, Iwona, Christine Matthews, Mark Catherwood, et al.. (2007). Telomeric IGH Losses Detectable by Fluorescence in Situ Hybridization in Chronic Lymphocytic Leukemia Reflect Somatic VH Recombination Events. Journal of Molecular Diagnostics. 9(1). 47–54. 29 indexed citations
2.
Catherwood, Mark, et al.. (2006). ZAP‐70 mRNA quantification in B‐cell chronic lymphocytic leukaemia. European Journal Of Haematology. 76(4). 294–298. 28 indexed citations
3.
Matthews, Christine, Mark Catherwood, T. C. M. Morris, & H. Denis Alexander. (2006). VH3–48 and VH3–53, as well as VH3–21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis. Leukemia Research. 31(2). 231–234. 12 indexed citations
4.
Matthews, Christine, Mark Catherwood, T. C. M. Morris, & H. Denis Alexander. (2004). Routine Analysis of IgVHMutational Status in CLL Patients using BIOMED-2 Standardized Primers and Protocols. Leukemia & lymphoma. 45(9). 1899–1904. 39 indexed citations
5.
Jaffe, Elaine S., et al.. (2004). Aggressive Natural Killer Cell Leukemia/Lymphoma: Case Report, use of Telesynergy™ and Review of the Literature. Leukemia & lymphoma. 45(6). 1269–1273. 8 indexed citations
6.
Xu, Jiru, John E. Moore, B. Cherie Millar, et al.. (2004). Improved Laboratory Diagnosis of Bacterial and Fungal Infections in Patients with Hematological Malignancies using PCR and Ribosomal RNA Sequence Analysis. Leukemia & lymphoma. 45(8). 1637–1641. 17 indexed citations
7.
Morris, T. C. M., et al.. (2003). Spontaneous splenic rupture in atypical (Philadelphia chromosome negative) chronic myeloid leukaemia following blastic crisis.. PubMed. 96(6). 181–2. 2 indexed citations
8.
Todd, Stephen, et al.. (2002). Myelodysplasia Terminating in Acute Myeloid Leukemia in a Hairy Cell Leukemia Patient Treated with 2-Deoxycoformycin. Leukemia & lymphoma. 43(6). 1343–1344. 7 indexed citations
9.
Lester, Will, et al.. (2000). Respiratory failure during induction chemotherapy for acute myelomonocytic leukaemia (FAB M4Eo) with Ara‐C and all‐trans retinoic acid. British Journal of Haematology. 109(4). 847–850. 8 indexed citations
10.
Morris, T. C. M., et al.. (1996). Vasculitis post-autologous transplant causing pulmonary shadows in a patient with Hodgkin's disease.. PubMed. 17(5). 869–70. 4 indexed citations
11.
Morris, T. C. M., et al.. (1994). Bone marrow necrosis. American Journal of Hematology. 47(3). 225–228. 28 indexed citations
12.
Bell, A. L., et al.. (1993). MYELOPEROXIDASE DEFICIENCY IN A PATIENT WITH RHEUMATOID ARTHRITIS: OXYGENATION AND RADICAL ACTIVITY BY PHAGOCYTIC CELLS. Lara D. Veeken. 32(2). 162–165. 12 indexed citations
13.
Morris, T. C. M., et al.. (1989). Immunoglobulin light chains in common acute lymphoblastic leukaemia. British Journal of Haematology. 71(1). 53–55. 2 indexed citations
14.
Morris, T. C. M., P. C. Vincent, G. A. R. Young, et al.. (1989). CFU-GM inhibitors in neutropenia. Clinical & Laboratory Haematology. 11(1). 31–45. 2 indexed citations
15.
Young, G. A. R., et al.. (1987). The CFU-C assay in patients with neutropenia and, in particular, drug associated neutropenia. Clinical & Laboratory Haematology. 9(3). 245–254. 4 indexed citations
16.
El-Agnaf, Moulod R., et al.. (1986). Successful remission induction with deoxycoformycin in elderly patients with T‐helper prolymphocytic leukaemia. British Journal of Haematology. 63(1). 93–104. 31 indexed citations
17.
Morris, T. C. M., et al.. (1984). CFU-C inhibitors in aplastic anaemia. Annals of Hematology. 48(2). 61–74. 6 indexed citations
18.
Irvine, Alexandra E., et al.. (1983). Ticarcillin-Induced Neutropenia Corroborated by in vitro CFU-C Toxicity. Acta Haematologica. 70(6). 364–368. 11 indexed citations
19.
Morris, T. C. M., et al.. (1983). Quantitative and Qualitative Deficiency of T-Lymphocyte Colony Formation in T-Cell Lymphoma-Leukaemia. Acta Haematologica. 69(4). 281–286. 3 indexed citations
20.
Morris, T. C. M., et al.. (1981). Auto‐anti‐B in a Patient with Acute Leukaemia. Vox Sanguinis. 41(4). 231–234. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazimierz Hałaburda Breakdown of academic impact, for papers by Tapio Nousiainen Breakdown of academic impact, for papers by Shoichi Inaba Breakdown of academic impact, for papers by Renée V. Gardner Breakdown of academic impact, for papers by Nicolas Bachot Breakdown of academic impact, for papers by Volkan Hazar Breakdown of academic impact, for papers by Alan Brox Breakdown of academic impact, for papers by Prassede Salutari Breakdown of academic impact, for papers by Gustav Fischmeister Breakdown of academic impact, for papers by Kanchana Chansung
Rankless by CCL
2026